Partner Winston Kirton has produced a second video for LexisNexis Practical Guidance titled “FDA-Regulated Company and Product Acquisition Diligence.” With private equity and merger and acquisition transactions on the rise, Kirton focuses on best practices for regulatory diligence on FDA-regulated company acquisitions, including the risk-based valuation approach.
Watch the video. (subscription required)